NKTR-214 short attack - Mr. Liu | DVAX Message Board Posts

Dynavax Technologies Corporation

  DVAX website

DVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1399 of 1888  at  11/12/2018 5:07:23 PM  by

fairvalueforyou


 In response to msg 1241 by  liuyiiv
view thread

Re: NKTR-214 short attack - Mr. Liu

NKTR-214 combo almost doubled CR rate from (ITT) CR 12% at June 2018 ASCO  to (ITT) 21% at SITC in stage IV previously untreated melanoma patients.
The key for its high CR is probably related to untreated late stage melanoma patients, and what is your take on its high CR?
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 167
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1400 Re: NKTR-214 short attack - Mr. Liu liuyiiv 5 11/12/2018 8:40:52 PM








Financial Market Data provided by
.
Loading...